| Shannon Joseph Krumm, CRNA | |
|
404 Jefferson St, Pella, IA 50219-1291 | |
| (641) 628-6634 | |
| (816) 461-6586 |
| Full Name | Shannon Joseph Krumm |
|---|---|
| Gender | Male |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 404 Jefferson St, Pella, Iowa |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801855713 | NPI | - | NPPES |
| 0206516 | Medicaid | IA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 103187 (Iowa) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Shannon Joseph Krumm, CRNA Po Box 1660, Independence, MO 64055-0660 Ph: (816) 461-8288 | Shannon Joseph Krumm, CRNA 404 Jefferson St, Pella, IA 50219-1291 Ph: (641) 628-6634 |
News Archive
In water-limited landscapes sick animals can have increased contact with healthy individuals, which can facilitate disease transmission. Scientists from the German Leibniz Institute for Zoo and Wildlife Research present these findings in the British Ecological Society journal Functional Ecology.
This year marks the 100th anniversary of the discovery of insulin, a scientific breakthrough that transformed Type 1 diabetes, once known as juvenile diabetes or insulin-dependent diabetes, from a terminal disease into a manageable condition.
Batten disease is a rare, fatal genetic disorder that affects children. Currently, no effective treatment exists for the disease, which ultimately kills all who are affected. Dachshunds also suffer from Batten disease, and now researchers from the University of Missouri College of Veterinary Medicine and School of Medicine, in collaboration with BioMarin Pharmaceutical Inc., have developed a treatment for the disease that has significantly delayed the onset and progression of symptoms in the Dachshunds.
Regulus Therapeutics Inc. announced today that the Company has received a $10 million equity investment from sanofi-aventis in connection with the landmark alliance the two companies entered into on June 21, 2010. The equity investment by sanofi-aventis further strengthens the balance sheet of Regulus, and with this investment sanofi-aventis becomes the third investor in Regulus, along with its founding companies Alnylam Pharmaceuticals, Inc. and Isis Pharmaceuticals, Inc..
› Verified 8 days ago
Andrew Joseph Johnson, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 405 Monroe St, Pella, IA 50219 Phone: 641-621-2201 Fax: 641-620-2050 | |
Timothy E Kinkade, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 404 Jefferson St, Pella, IA 50219 Phone: 641-628-6634 Fax: 913-381-0979 | |
Andrew J Hunsinger, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 404 Jefferson St, Pella, IA 50219 Phone: 641-628-6634 Fax: 641-621-2458 | |
Michael G Salter, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 404 Jefferson St, Pella, IA 50219 Phone: 641-628-3150 Fax: 816-461-6586 |